about
Declaration of Helsinki should be strengthened.Placebos and placebo effects in medicine: historical overviewAre experimental treatments for cancer in children superior to established treatments? Observational study of randomised controlled trials by the Children's Oncology GroupConcept of true and perceived placebo effectsThe revision of the Declaration of Helsinki: past, present and futureReactions to treatment debriefing among the participants of a placebo controlled trial.Equivalence and noninferiority trials - are they viable alternatives for registration of new drugs? (III)The Cure Rate after Placebo or No Therapy in American Cutaneous Leishmaniasis: A Systematic Review and Meta-AnalysisClinical application of paroxetine for tapering benzodiazepine use in non-major-depressive outpatients visiting an internal medicine clinicPlacebo orthodoxy in clinical research. I: Empirical and methodological mythsVulnerability in clinical research with patients in pain: a risk analysis.Assessing overall evidence from noninferiority trials with shared historical data.A systematic review of antidepressant placebo-controlled trials for geriatric depression: limitations of current data and directions for the future.Misclassification in administrative claims data: quantifying the impact on treatment effect estimates.Non-inferiority and networks: inferring efficacy from a web of data.Safety of research into severe and treatment-resistant mood disorders: analysis of outcome data from 12 years of clinical trials at the US National Institute of Mental Health.Daily home fortification with iron as ferrous fumarate versus NaFeEDTA: a randomised, placebo-controlled, non-inferiority trial in Kenyan childrenWhen placebo controlled trials are essential and equivalence trials are inadequate.Long-term (5 year) safety of bronchial thermoplasty: Asthma Intervention Research (AIR) trial.Ethics in clinical research: searching for absolutesVenlafaxine and treatment-resistant depression.The ethics of clinical trials: a child's view.Substituting placebo for established, effective therapy: why not?The ethical relevance of the standard of care in the design of clinical trials.Randomised trialomania? The multicentre liver transplant trials of tacrolimus.Tacrolimus (FK506) and the pharmaceutical/academic/regulatory gauntletAn algorithm for evaluating the ethics of a placebo-controlled trial.Medication-free research in early episode schizophrenia: evidence of long-term harm?Clinical trials in the 21st century: the case for participant-centered research.Treating posttraumatic stress disorder with MDMA-assisted psychotherapy: A preliminary meta-analysis and comparison to prolonged exposure therapy.Guidelines for trials of behavioral treatments for recurrent headache, first edition: American Headache Society Behavioral Clinical Trials Workgroup.Drug efficacy by direct and adjusted indirect comparison to placebo: An illustration by Mycobacterium avium complex prophylaxis in HIVPlacebo-controlled clinical trials: how trial documents justify the use of randomisation and placebo.Clinical trials of drugs used off-label in neonates: ethical issues and alternative study designs.The randomized controlled trial in studies using biomarkers.Evaluation of new therapies for inflammatory bowel disease.Toward rapproachment in the placebo control debate. A calculated compromise of power.Evaluation of new treatments in radiation oncology: are they better than standard treatments?Ethics in psychiatric research: study design issues.Comparing the efficacy of NSAIDs and paracetamol in children.
P2860
Q24527292-9DC23982-75DF-4564-8287-9C6D3299E5C4Q24536191-C3146EA9-B4A9-4833-B10E-5AE93B5B250BQ24536914-CED85719-15E6-4C79-B778-CDA1E797775AQ24645411-D2A2E5B1-902D-4452-B8EA-C18AE0C90C33Q24679200-37C2AB37-D686-413D-AB56-093A2A81FC92Q24803625-1BF69F74-8CDA-4CE6-8730-FD7E3750ED86Q24803870-B4390120-2C81-4637-A38A-740D85ACE6B1Q26764752-AB4D73D4-B285-401F-A78F-CA22438A2A79Q28262343-AB2EAAAE-0608-4211-B9AD-2C045ECBB608Q28305894-2A1C91DC-9C25-4482-B082-BE4ED53C3510Q30431269-9B272B64-117C-49EA-807B-563EC9818019Q30567163-D7D05702-1350-458E-8BE1-2DC99CD790DAQ30955590-2CE68CA0-7AD0-4125-B963-27E8A1535C1FQ30974376-86A84038-34B2-4FD2-8BE7-83A61BFE09EDQ31030399-F7028D3C-DA97-4E71-904D-2625F3597514Q31057535-9096A0AF-A29A-4AC5-B12C-451EF3476E08Q33612551-797BCF63-F3EF-46D5-8837-195C5067175DQ33792013-3D535181-FB68-4B82-94E6-EBC5761C9AB7Q33818701-B179BAE5-068F-4E19-BB9B-F973781FE580Q34028639-678FB58E-05C0-4A1B-ABE7-0BB55639414CQ34093707-08FAB2CD-F70A-4E26-AC8B-B1353025363EQ34228770-A9113405-D670-44F9-A8E1-2DB9965B3424Q34273925-59820BCC-F1FD-4235-8385-6D7E77E7C917Q34287158-C5A31B3D-7D1E-49CE-B1DA-5BE01268C83DQ34289636-A3AFE73F-986F-498A-9450-EF8379071862Q34340969-983F982D-AFCE-44D7-B2A1-2063A42632FFQ34388286-9668A89B-12FC-47A1-98D6-D41DA0F6A3DAQ34463497-E375F64F-1906-47AC-9108-1385619DB3E1Q34464504-35A5CC6F-69F2-4546-8E32-2EDD6A699BF2Q34523797-1041077F-8D06-4C0B-86A5-8C79B743109EQ34650608-5CC5A8BE-B008-4CAA-BB45-866C97C06EBCQ34727977-775AC75D-7C4F-40F5-A497-12C6F81B868EQ34981543-0B66C14E-1CD4-424F-A09E-009FC0EAD921Q35012585-CA663BA0-A5C0-418B-87AB-873E938DE3B0Q35041950-2A2EFD30-FF84-4BAC-854E-A7C3B6C627D4Q35216827-C98D04EA-EEEA-47EE-B2BC-A1D825E503FEQ35590559-B9825D2F-36FB-4838-A039-9054C7218659Q35606349-1BABC405-9D36-42EE-AAF0-3C464DE633C2Q35649190-E692EAB3-6229-4D3D-A69A-AB4AF3B9F1BBQ35680419-AD830E4E-78E3-4C90-97B0-B04C52478D4E
P2860
description
1994 nî lūn-bûn
@nan
1994 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
The continuing unethical use of placebo controls
@ast
The continuing unethical use of placebo controls
@en
The continuing unethical use of placebo controls
@nl
type
label
The continuing unethical use of placebo controls
@ast
The continuing unethical use of placebo controls
@en
The continuing unethical use of placebo controls
@nl
prefLabel
The continuing unethical use of placebo controls
@ast
The continuing unethical use of placebo controls
@en
The continuing unethical use of placebo controls
@nl
P1476
The continuing unethical use of placebo controls
@en
P2093
Michels KB
P304
P356
10.1056/NEJM199408113310611
P407
P577
1994-08-01T00:00:00Z